Search

everythinglearnresearchcommunity

for

Search:↓

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

A male with aromatase deficiency improved bone health with estradiol treatment.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride reduces alcohol withdrawal effects, especially in female mice.

Finasteride doesn't affect bone density in male rats.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.